2019 Projects

Determining genetic and microbiome effects on non-alcoholic fatty liver disease and its medical complications in a Chinese population
Elizabeth Speliotes, MD, PhD, MPH
Linong Ji, MD
2019
LILRA3 as a novel regulator of thrombioinflammation in antiphospholipid syndrome (APS)
Jason Knight, MD, PhD
Jianping Guo, MD, PhD
2019
Molecular signatures underlying the progression of intestinal meaplasia: a multi-omics approach
Andrea Tosisco, MD
John Kao, MD
Wen-Qing Li, PhD
2019
Gaining insight into retinal cell death: rational drug development through vitreous proteomic analysis
David Zacks, MD, PhD
Liu Yang, MD, PhD
2019
Citrullinated Histone H3: A Mediator and Biomarker of Sepsis-induced Acute Lung Injury
Yongqing Li, MD, PhD
Tianbing Wang, MD
2019
Michigan-Peking Cancer Biomarker Collaborative
Arul Chinnaiyan, MD, PhD
Yuxin Yin, MD, PhD
2019
EMERALD-HF: Evaluation of MinERalocorticoid antagonists in ALdehyde dehydrogenase type 2 Deficiency
Bertram Pitt, MD
Porama Thanaporn, MD
Wei Gao, MD
2019
New Strategy to Identify, Validate, and Eliminate Heterogeneity for Personalized Cancer Therapy of Breast Cancer or Liver Cancer
Duxin Sun, PhD
Ning Zhang, PhD
2019
Deferoxamine in the Treatment of Aneurysmal Subarachnoid Hemmorrhage (DISH)
Aditya Pandey, MD
Yining Huang, MD
2019
Building a Learning Health System for Kidney Disease through Meaningful Use of Electronic Health Record Data in Yinzhou China
Charles Friedman, PhD
Luxia Zhang, MD
2019